Pantoprazole for Injection 40mg Taj Pharma

Pantoprazole for Injection 40mg Taj Pharma

Name of the medicinal product Pantoprazole for Injection 40mg Taj Pharma Qualitative and quantitative composition Pantoprazole for Injection 40mg Each vial contains: Pantoprazole Sodium (sterile, Lyophilized) eq to Pantoprazole                                           40mg Pharmaceutical form Powder for solution for injection. White to almost white powder. Clinical particulars 4.1 Therapeutic indications – Reflux oesophagitis – Gastric and duodenal ulcer […]

Read more
Mesalazine Pellets – PR Granules 0.5g (MESALATAJ) Taj Pharma

Mesalazine Pellets – PR Granules 0.5g (MESALATAJ) Taj Pharma

NAME OF THE MEDICINAL PRODUCT Mesalazine Pellets Prolonged Release Granules 0.5g Taj Pharma Mesalazine Pellets Prolonged Release Granules 1g Taj Pharma Mesalazine Pellets Prolonged Release Granules 2g Taj Pharma QUALITATIVE AND QUANTITATIVE COMPOSITION a) Each sachet contains: Mesalazine……………………….0.5g b) Each sachet contains: Mesalazine………………………..1gc) Each sachet contains: Mesalazine……………………….2g For a full list of excipients, see section […]

Read more
Rabeprazole Sodium Gastro-Resistant Tablets IP 20mg (RABTAJ) Taj Pharma

Rabeprazole Sodium Gastro-Resistant Tablets IP 20mg (RABTAJ) Taj Pharma

Name of the medicinal product Rabeprazole Sodium Gastro-Resistant Tablets IP 10mg (RABTAJ) Taj Pharma Rabeprazole Sodium Gastro-Resistant Tablets IP 20mg (RABTAJ) Taj Pharma Rabeprazole Sodium Gastro-Resistant Tablets IP 40mg (RABTAJ) Taj Pharma Qualitative and quantitative compositiona) Each gastro-resistant tablet contains: Rabeprazole sodium, equivalent to Rabeprazole IP……………………………10mg b) Each gastro-resistant tablet contains: Rabeprazole sodium, equivalent to Rabeprazole […]

Read more
Pantoprazole (EC) and Dompiridone (SR) Capsules 40mg/30mg (PANTOTAJ – DSR) Taj Pharma

Pantoprazole (EC) and Dompiridone (SR) Capsules 40mg/30mg (PANTOTAJ – DSR) Taj Pharma

Name of the medicinal product Pantoprazole (EC) and Dompiridone (SR) Capsules 40mg/30mg (PANTOTAJ – DSR) Taj Pharma Composition  Each hard gelatin Capsule contains: Pantoprazole Sodium IP Equibvalent to Pantoprazole 40mg (As enteric coated granules) Domperidone IP 30mg (As sustained release granules) Excipients q.s. 3.PHARMACEUTICAL FORM: Capsule for oral administration 4.CLINICAL PARTICULARS: 4.1 Therapeutic indications: Gastro-esophageal […]

Read more
Mesalamine Delayed-Released Tablets USP 400mg Taj Pharma

Mesalamine Delayed-Released Tablets USP 400mg Taj Pharma

NAME OF THE MEDICINAL PRODUCT Mesalamine Delayed-Released Tablets USP 400mg Taj Pharma Mesalamine Delayed-Released Tablets USP 800mg Taj Pharma Mesalamine Delayed-Released Tablets USP 1.2g Taj Pharma QUALITATIVE AND QUANTITATIVE COMPOSITION  a) Each Delayed Released Tablet contains: Mesalamine USP…………………….400mg|b) Each Delayed Released Tablet contains: Mesalamine USP…………………….800mg b) Each Delayed Released Tablet contains: Mesalamine USP…………………….1.2g PHARMACEUTICAL FORM […]

Read more
Nizatidine Capsules USP 300mg Taj Pharma

Nizatidine Capsules USP 300mg Taj Pharma

Nizatidine Capsules USP 300mg Taj Pharma Name of the medicinal product Nizatidine 150mg Capsules Taj Pharma Nizatidine 300mg Capsules Taj Pharma Qualitative and quantitative composition Each capsule contains Nizatidine USP             150mg Excipients                      q.s Each capsule contains Nizatidine USP             300mg Excipients                      q.s Excipient with known effect: For the full list of excipients, see section 6.1. Pharmaceutical […]

Read more
Nizatidine Capsules USP 150mg Taj Pharma

Nizatidine Capsules USP 150mg Taj Pharma

Nizatidine Capsules USP 150mg Taj Pharma Name of the medicinal product Nizatidine 150mg Capsules Taj Pharma Nizatidine 300mg Capsules Taj Pharma Qualitative and quantitative composition Each capsule contains Nizatidine USP             150mg Excipients                      q.s Each capsule contains Nizatidine USP             300mg Excipients                      q.s Excipient with known effect: For the full list of excipients, see section 6.1. Pharmaceutical […]

Read more